Stock Quote
Alexza Pharmaceuticals, Inc. (ALXA.W) (NASD ADF)
sector: Healthcare .
industry: Pharmaceuticals - Generic & Specialty ยท
View ALXA on other exchanges
$2.15
12 Nov 2009
+2.38%
$2.10
$2.15
100
$2.15
$2.15
$3.53
$1.16
1.83
128,997
ALXA.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| King, Thomas | President, Chief Executive Officer, Director | 987,637 |
| Moretti, August | Chief Financial Officer, Senior Vice President, Secretary | 629,028 |
| Cassella, James | Senior Vice President - Research and Development | 691,558 |
Profile
Alexza Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of acute and intermittent conditions. The Company has six product candidates in clinical development. Its technology, the Staccato system, vaporizes... Full Description
Company Address
Alexza Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
P: +1650.6873900
F: +1650.6873999
1020 East Meadow Circle
Palo Alto CA 94303
P: +1650.6873900
F: +1650.6873999
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Johnson & Johnson | $62.67 | +0.36 |
| Pfizer Inc. | $18.60 | +0.24 |
| GlaxoSmithKline plc | £1,277.50 | +24.00 |
| ALXA.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.57 |
| P/S(TTM) | 7.58 | 0.57 |
| ROI(TTM) | -90.52 | 1.86 |
| ROE(TTM) | -94.73 | 2.51 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -0.22 |
| EPS Est. (Current Year) | -2.08 |
| Total Revenue | $0.00M |
| Net Income | $-16.97M |
| EPS | $-0.29 |
